SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-059980
Filing Date
2018-11-14
Accepted
2018-11-14 16:32:37
Documents
56
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv506373_10q.htm 10-Q 488684
2 EXHIBIT 31.1 tv506373_ex31-1.htm EX-31.1 7116
3 EXHIBIT 31.2 tv506373_ex31-2.htm EX-31.2 7089
4 EXHIBIT 32.1 tv506373_ex32-1.htm EX-32.1 3786
5 EXHIBIT 32.2 tv506373_ex32-2.htm EX-32.2 3765
  Complete submission text file 0001144204-18-059980.txt   5144852

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT capr-20180930.xml EX-101.INS 1352162
7 XBRL TAXONOMY EXTENSION SCHEMA capr-20180930.xsd EX-101.SCH 48542
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE capr-20180930_cal.xml EX-101.CAL 29160
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE capr-20180930_def.xml EX-101.DEF 296018
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE capr-20180930_lab.xml EX-101.LAB 326445
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE capr-20180930_pre.xml EX-101.PRE 321092
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 181184444
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1